Vitrac therapeutics initiated global clinical development of vic-1911, licensed from taiho pharmaceutical

Vitrac therapeutics, llc (vitrac) initiated the global clinical development of vic-1911, an oncology candidate formally known as tas-119, which was li

CYCC Ratings Summary

CYCC Quant Ranking